News and Latest Activity April 28th 2025ImmunoKey announces a strategic collaboration with OxTium, an AI-driven technology company, to Advance target discovery for CAR T-Cell TherapiesApril 3rd 2025ImmunoKey Selected for Bruntwood Life Science Accelerator 2025 Cohort
